JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023

Final dividend in cash for the year ended December 31, 2022

Final dividend in cash for the year ended December 31, 2022

Final dividend in bonus shares for the year ended December 31, 2022

Final dividend in bonus shares for the year ended December 31, 2022

(1) POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING, THE FIRST A SHARE CLASS MEETING FOR 2023 AND THE FIRST H SHARE CLASS MEETING FOR 2023 AND (2) ISSUE OF CAPITALIZATION SHARES AND PAYMENT OF CASH DIVIDEND AND (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATIO

(1) POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING, THE FIRST A SHARE CLASS MEETING FOR 2023 AND THE FIRST H SHARE CLASS MEETING FOR 2023 AND (2) ISSUE OF CAPITALIZATION SHARES AND PAYMENT OF CASH DIVIDEND AND (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATIO

Final dividend in cash for the year ended December 31, 2022

Final dividend in cash for the year ended December 31, 2022

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top